Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy

Laura Toussaint*, Witold Matysiak, Claire Alapetite, Javier Aristu, Agata Bannink-Gawryszuk, Stephanie Bolle, Alessandra Bolsi, Felipe Calvo, Fernando Cerron Campoo, Frances Charlwood, Charlotte Demoor-Goldschmidt, Jérôme Doyen, Katarzyna Drosik-Rutowicz, Pauline Dutheil, Anna Embring, Jacob Engellau, Anneleen Goedgebeur, Farid Goudjil, Semi Harrabi, Renata KopecIngrid Kristensen, Peter Lægsdmand, Carola Lütgendorf-Caucig, Arturs Meijers, Alfredo Mirandola, Fernand Missohou, Marta Montero Feijoo, Ludvig P Muren, Barbora Ondrova, Ester Orlandi, Erik Pettersson, Alessia Pica, Sandija Plaude, Roberto Righetto, Barbara Rombi, Beate Timmermann, Karen Van Beek, Anthony Vela, Sabina Vennarini, Anne Vestergaard, Marie Vidal, Vladimir Vondracek, Damien C Weber, Gillian Whitfield, Jens Zimmerman, John H Maduro, Yasmin Lassen-Ramshad

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    2 Citations (Scopus)
    56 Downloads (Pure)

    Abstract

    BACKGROUND AND PURPOSE: As no guidelines for pencil beam scanning (PBS) proton therapy (PT) of paediatric posterior fossa (PF) tumours exist to date, this study investigated planning techniques across European PT centres, with special considerations for brainstem and spinal cord sparing.

    MATERIALS AND METHODS: A survey and a treatment planning comparison were initiated across nineteen European PBS-PT centres treating paediatric patients. The survey assessed all aspects of the treatment chain, including but not limited to delineations, dose constraints and treatment planning. Each centre planned two PF tumour cases for focal irradiation, according to their own clinical practice but based on common delineations. The prescription dose was 54 Gy(RBE) for Case 1 and 59.4 Gy(RBE) for Case 2. For both cases, planning strategies and relevant dose metrics were compared.

    RESULTS: Seventeen (89 %) centres answered the survey, and sixteen (80 %) participated in the treatment planning comparison. In the survey, thirteen (68 %) centres reported using the European Particle Therapy Network definition for brainstem delineation. In the treatment planning study, while most centres used three beam directions, their configurations varied widely across centres. Large variations were also seen in brainstem doses, with a brainstem near maximum dose (D2%) ranging from 52.7 Gy(RBE) to 55.7 Gy(RBE) (Case 1), and from 56.8 Gy(RBE) to 60.9 Gy(RBE) (Case 2).

    CONCLUSION: This study assessed the European PBS-PT planning of paediatric PF tumours. Agreement was achieved in e.g. delineation-practice, while wider variations were observed in planning approach and consequently dose to organs at risk. Collaboration between centres is still ongoing, striving towards common guidelines.

    Original languageEnglish
    Article number110414
    Number of pages8
    JournalRadiotherapy and Oncology
    Volume198
    DOIs
    Publication statusPublished - Sept-2024

    Keywords

    • Humans
    • Proton Therapy/methods
    • Infratentorial Neoplasms/radiotherapy
    • Europe
    • Child
    • Radiotherapy Planning, Computer-Assisted/methods
    • Radiotherapy Dosage
    • Child, Preschool
    • Male
    • Female
    • Organs at Risk/radiation effects
    • Brain Stem/radiation effects

    Fingerprint

    Dive into the research topics of 'Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy'. Together they form a unique fingerprint.

    Cite this